SPHK1 and metabolic dysfunction-associated steatotic liver disease: To investigated whether SphK1 expression is increased in the livers of patients with MASLD, we examined the mRNA expression levels of SphK1 in MASH livers and compared them with those in normal livers obtained from liver biopsy or hepatectomy.